Research output per year
Research output per year
Search results
-
2022
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, In: Journal for ImmunoTherapy of Cancer. p. A1300-A1300Research output: Journal article (peer-reviewed) › Conference contribution to journal
Open Access -
Die Auswirkung von Osteoblasten und deren Präkursoren auf das Schicksal von Brustkrebszellen: Abstracts
Lind, J., Gassner, T., Aksoy, O., Sunder-Plaßmann, V., Pecherstorfer, M., Podar, K. & Vallet, S., 27 Sept 2022, In: Oncology Research and Treatment. 45, Suppl. 2, p. 5-346 342 p., P360.Research output: Journal article (peer-reviewed) › Conference contribution to journal
Open Access2 Citations (Scopus) -
2021
OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria
Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S19-S20Research output: Journal article (peer-reviewed) › Conference contribution to journal
-
P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria
Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S83-S84Research output: Journal article (peer-reviewed) › Conference contribution to journal